HomeNXTCL • STO
add
NextCell Pharma AB
Previous close
kr 0.68
Day range
kr 0.66 - kr 0.72
Year range
kr 0.63 - kr 3.84
Market cap
77.65M SEK
Avg Volume
253.00K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Aug 2025info | Y/Y change |
|---|---|---|
Revenue | 2.52M | 48.67% |
Operating expense | 9.11M | 11.08% |
Net income | -8.63M | 34.85% |
Net profit margin | -342.26 | 56.18% |
Earnings per share | — | — |
EBITDA | -8.18M | 36.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Aug 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.72M | -17.24% |
Total assets | 76.73M | -5.60% |
Total liabilities | 10.34M | -24.44% |
Total equity | 66.39M | — |
Shares outstanding | 111.39M | — |
Price to book | 1.14 | — |
Return on assets | -34.10% | — |
Return on capital | -40.91% | — |
Cash Flow
Net change in cash
| (SEK) | Aug 2025info | Y/Y change |
|---|---|---|
Net income | -8.63M | 34.85% |
Cash from operations | -10.77M | -35.46% |
Cash from investing | -1.73M | -294,986.03% |
Cash from financing | 34.52M | 1.68% |
Net change in cash | 22.01M | -15.31% |
Free cash flow | -9.37M | -187.58% |
About
Founded
2014
Website
Employees
24
